Company and Stock Identity

How Ever Fortune.AI Connects to the Public Market

Company structure
Private company, no listing verified
Market access
No current public listing was verified.
Research focus
This company is the clearest example of why counting clearances beats reading marketing. Seven United States clearances is a lot, and the group test still applies: a clearance covers one finding on one kind of scan, not everything a product page suggests. Ever Fortune.AI spreads across radiotherapy contouring, chest X-ray, bone scan, bone density, cardiac perfusion and emergency CT, so ask which clearance covers the use you care about. Its evidence and its reference hospitals are largely Taiwanese, which matters because a model trained on one population can behave differently on another, and its own research notes include a claim of 84 percent faster radiotherapy contouring that this desk has not seen data behind.

The company pages, read on 2026-10-31, give the head office as the 8th floor, number 360, section 1 Jingmao Road, Beitun District, Taichung City 406040, Taiwan, and the same address appears on its United States 510(k) records. Its chairman is named as Dr Ming-Feng Chen, with positions at China Medical University Hospital and National Taiwan University Hospital. No owner or parent is named. Its own news page publishes monthly group revenue figures, including a 12 percent year on year rise for May 2026, which is the kind of disclosure a listed Taiwanese company makes, but no exchange or ticker is stated anywhere on its own pages, so this record does not claim a listing. Checked on 2026-10-31.

Open the public company market data feed for the full directory, ownership relationships, stock identifiers, and dated snapshots.

First-Hand Company News

Latest Developments

... FDA 510(k) Premarket Notification Database ... Regulatory record

Ever Fortune.AI clears a CT appendicitis triage system with the FDA

The FDA 510(k) record K253163 shows a decision date of 22 April 2026 and a decision of substantially equivalent for the EFAI ERSUITE CT APPENDICITIS ASSESSMENT SYSTEM, model APPEN-CT-100. The applicant is Ever Fortune.Ai, Co., Ltd. of Taichung City, Taiwan. The record gives regulation number 892.2080, product code QAS, and the classification radiological computer-assisted triage and notification software, and lists the submission as traditional. A 510(k) clearance means the FDA found the device substantially equivalent to one already on the market. It is not an approval and it is not a finding that the software improves care.

Why it matters: The classification is the whole story. Triage and notification software is cleared to change the order of a worklist, not to make the diagnosis, so what this product is allowed to do is move a suspected appendicitis scan in front of a radiologist sooner. That is genuinely useful in a busy emergency department and it is a narrow claim, which is the honest way to read it. Note what the record does not contain: no sensitivity, no specificity, no study population and nothing about the hospitals the software was tested in. A clearance under this classification is also one of the most common in healthcare AI, so holding seven of them says this company can get through the process, not that any one product outperforms a rival.

See company developments across the healthcare AI market.

Careers and Qualifications

What to Know Before Applying

Work areas: The careers page explains the hiring steps rather than listing roles, saying openings are published from time to time on outside job boards. It describes resume screening by the recruitment team and the hiring manager, then interviews with one or more supervisors, sometimes after a written technical test, then a background check and a phone offer. The company describes its staff as physicians, data scientists and software engineers.

Qualification signal: A company with seven United States clearances and a Taiwanese research base needs people who can do regulatory work in two languages and two systems, which is a narrow and valuable skill. For technical roles, the useful experience is medical imaging specifically, because the products are all image reading rather than text. Ask which market a role serves, since building for Taiwanese hospitals and submitting to the United States regulator are different jobs.

Check current roles at Ever Fortune.AI. A careers page is the source of record for openings. This profile does not claim a role is open unless the company lists it now.

Related Healthcare AI Roles

Training to Compare

Buyer Snapshot

Best-fit buyer
Radiology leadership, pathology leadership, clinical informatics, imaging IT, patient safety, and procurement
Primary use case
Triage studies, flag findings, support image interpretation, and coordinate time-sensitive care
Typical deployment
Usually integrated with PACS, RIS, worklists, or digital pathology systems and monitored inside the clinical workflow

Evidence questions

  • Was the tool tested prospectively and independently on comparable equipment and patients?
  • What are sensitivity, specificity, false positive workload, and time-to-action effects?
  • How does performance vary by site, scanner, demographic subgroup, and disease prevalence?

Regulatory and workflow questions

  • Which FDA authorization covers the exact product version, modality, and intended use?
  • Who retains final clinical responsibility and how is disagreement with the AI handled?
  • What post-deployment monitoring and material update notification does the vendor provide?

Data and contract questions

  • Where are images and derived data processed and retained?
  • Which PACS, RIS, pathology, and EHR integrations are supported in production?
  • Can data be used for model improvement, and what controls govern secondary use?

Evidence and Regulation

FDA Clearances on Record

Ever Fortune.AI appears on 7 cleared products in the federal 510(k) record, across 2 device types.

A clearance means the FDA agreed the product is close enough to something already on the market to be sold for that use. It is not a finding that the product helps patients, and it is not a ranking against anything else on this page. A company is linked to an FDA clearance only when the 510(k) applicant name on the government record is confirmed by hand to be that same company, including former corporate names. Name similarity alone is never enough, and rejected matches are listed below with the reason.

What the Published Research Says About This Work

Independent studies on the work itself help separate category evidence from one company's claims.

First-Hand Sources